CircMED13L_012 promotes lung adenocarcinoma progression by upregulation of MAPK8 mediated by miR-433-3p

BACKGROUND: Metastasis and disease refractoriness remain as major challenges for non-small cell lung cancer (NSCLC) treatment and understanding the underlying molecular mechanisms is of scientific and clinical value. Therefore, in this study, we aimed to explore the effects of circMED13L_012 on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenshu, Zheng, Guanying, Huang, Jianyuan, Zhu, Lihuan, Li, Wujin, Guo, Tianxing, Huang, Yangyun, Pan, Xiaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885357/
https://www.ncbi.nlm.nih.gov/pubmed/33593390
http://dx.doi.org/10.1186/s12935-021-01811-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885357/
https://www.ncbi.nlm.nih.gov/pubmed/33593390
http://dx.doi.org/10.1186/s12935-021-01811-4

Ejemplares similares